Stock Price
20.91
Daily Change
0.55 2.70%
Monthly
-19.58%
Yearly
-19.89%
Q1 Forecast
19.91

Pacira reported $157.68M in Stock for its fiscal quarter ending in September of 2025.





Stock Change Date
Astellas Pharma JPY 297.26B 9.92B Mar/2025
Bristol-Myers Squibb USD 2.76B 21M Sep/2025
J&J USD 14.15B 734M Sep/2025
Ligand Pharmaceuticals USD 11.9M 3.59M Sep/2025
Novo Nordisk DKK 45.65B 21.26B Jun/2025
Pacira USD 157.68M 9.52M Sep/2025
Perrigo USD 1.23B 11.5M Sep/2025
Pfizer USD 11.47B 201M Sep/2025
Supernus Pharmaceuticals USD 107.1M 63.08M Sep/2025
Teva Pharmaceutical Industries USD 3.18B 144M Dec/2025
Xeris Pharmaceuticals USD 67.46M 182K Sep/2025
Zoetis USD 2.47B 26M Sep/2025